Início › Glioblastoma › Califórnia

Ensaios clínicos de Glioblastoma em Califórnia

40 estudos para Glioblastoma estão buscando participantes em locais em Califórnia.

Cidades em Califórnia

Texto oficial do estudo (Inglês)

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

City of Hope Comprehensive Cancer Center, Duarte
UC San Diego Moores Cancer Center, La Jolla
Los Angeles General Medical Center, Los Angeles
e mais 2

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT05432804

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

University of California, San Diego, La Jolla
Cedars Sinai - Samuel Oschin Comprehensive Cancer Institute, Los Angeles
St. Joseph Hospital, Orange

RecrutandoFase 2/3

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT03970447

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Kaiser Permanente, Los Angeles
UCLA, Los Angeles
Sutter Health - California Pacific Medical Center, San Francisco
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 29 de set. de 2026 · NCT05902169

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

UCSD Moores Cancer Center, La Jolla
Cedars-Sinai Medical Center, Los Angeles
Stanford University, Palo Alto

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07326566

A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM

University of California San Diego, San Diego
University of California San Francisco, San Francisco

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05303467

Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma

University of California Davis Comprehensive Cancer Center, Sacramento

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT07145112

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Children's Hospital Los Angeles, Los Angeles
University of California at Los Angeles, Los Angeles

RecrutandoFase 1/2

Até 25 anos · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT04094610

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Precision NextGen Oncology, Beverly Hills
OPN Healthcare, Inc, Glendale
University of Southern California, Los Angeles

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2026 · NCT06047379

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

Cedars-Sinai Medical Center, Los Angeles

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT04977375

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de set. de 2026 · NCT07089641

Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma

UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
USC / Norris Comprehensive Cancer Center, Los Angeles
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
e mais 1

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT07452458

A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors

City of Hope - Duarte Cancer Center, Duarte
UCLA Health Bowyer Oncology Center, Los Angeles
UCSF Helen Diller Medical Center at Parnassus Heights - Neurology, San Francisco
e mais 1

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT06914128

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

University of California, Los Angeles (Data Collection Only), Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT06934889

Multiple Intracerebral Doses of Neural Stem Cell-Based Virotherapy (NSC-CRAd-S-pk7) for the Treatment of Recurrent High-Grade Gliomas

City of Hope Medical Center, Duarte
Standford University, Stanford

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT05139056

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

City of Hope Comprehensive Cancer Center, Duarte
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
UC San Diego Moores Cancer Center, La Jolla
e mais 2

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06860594

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

University of California San Diego, La Jolla
University of California, Los Angeles, Los Angeles
Hoag Memorial Hospital Presbyterian, Newport Beach
e mais 2

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 28 de ago. de 2026 · NCT05303519

Identifying Findings on Brain Scans That Could Help Make Better Predictions About Brain Cancer Progression, The GABLE Trial

Cedars-Sinai Medical Center, Los Angeles

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT06319027

Anti-EGFRvIII synNotch Receptor Induced Anti-EphA2/IL-13Ralpha2 CAR (E-SYNC) T Cells

University of California, San Francisco, San Francisco

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 13 de ago. de 2026 · NCT06186401

Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas

City of Hope Medical Center, Duarte

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT07544992

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

Cedars-Sinai Medical Center, Los Angeles
University of California, San Francisco, San Francisco
Pacific Neuroscience Institute / Saint John's Cancer Institute, Santa Monica

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT05708352

A Multicenter Trial to Identify Optimal Atezolizumab Biomarkers in the Setting of Recurrent Glioblastoma. The MOAB Trial

University of California, San Francisco, San Francisco

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT06069726

DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

City of Hope, Duarte
HOAG, Newport Beach
UCSF, San Francisco

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de jul. de 2026 · NCT06805305

Intracranial Genetically Modified Immune Cells (TGFβR2KO/IL13Rα2 CAR T-Cells) for the Treatment of Recurrent or Progressive Glioblastoma or Grade 3 or 4 IDH-Mutant Astrocytoma

City of Hope Medical Center, Duarte

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 29 de jun. de 2026 · NCT06815029

Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer

City of Hope Medical Center, Duarte

RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos

Idades 18 e acima · Todos os sexos · Atualizado em 24 de jun. de 2026 · NCT07664579

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

University of California, Los Angeles (UCLA) Department of Medicine - Hematology/Oncology, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 23 de jun. de 2026 · NCT04678648

ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

University of California, San Francisco, San Francisco

RecrutandoFase 1

Idades de 2 a 21 · Todos os sexos · Atualizado em 11 de jun. de 2026 · NCT04732065

PH Sensitive MRI Based Resections of Glioblastoma

Ronald Reagan Medical Center, Los Angeles

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 4 de mai. de 2026 · NCT06176066

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Beckman Research Institute of City of Hope, Duarte
VA Medical Center, Fresno, Fresno
Santa Clara Valley Medical Center, Fruitdale
e mais 5

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 30 de abr. de 2026 · NCT05297734

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

University of California, Irvine, Irvine
University of California Los Angeles, Los Angeles
University of California at San Francisco, San Francisco

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 13 de abr. de 2026 · NCT06810544

Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

RecrutandoFase 3

Idades 18 e acima · Todos os sexos · Atualizado em 10 de mar. de 2026 · NCT07461948

Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

Recrutando

Idades 18 e acima · Todos os sexos · Atualizado em 10 de nov. de 2025 · NCT06090903

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Duarte
Massive Bio SYNERGY-AI site, Irvine
Massive Bio SYNERGY-AI site, La Jolla
e mais 3

RecrutandoEstudo observacional

Todas as idades · Todos os sexos · Atualizado em 28 de out. de 2025 · NCT03452774

Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells

University of California at Los Angeles, Los Angeles

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 8 de out. de 2025 · NCT06059690

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Cedars Sinai Medical Center, Los Angeles

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 24 de set. de 2025 · NCT05941507

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Cedars-Sinai Medical Center - Samuel Oschin Comprehensive Cancer Institute, Los Angeles

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 27 de jun. de 2025 · NCT03175224

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

University of California, San Francisco, San Francisco

RecrutandoEstudo observacional

Idades de 18 a 90 · Todos os sexos · Atualizado em 28 de fev. de 2024 · NCT06283927

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

University of California, San Francisco, San Francisco

RecrutandoEstudo observacional

Até 90 anos · Todos os sexos · Atualizado em 22 de fev. de 2024 · NCT06273176

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

University of California, San Francisco (UCSF), San Francisco

RecrutandoEstudo observacional

Idades de 18 a 90 · Todos os sexos · Atualizado em 22 de fev. de 2024 · NCT06118723

The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)

University of California, San Francisco, San Francisco

RecrutandoEstudo observacional

Idades de 18 a 90 · Todos os sexos · Atualizado em 27 de nov. de 2023 · NCT06146738

The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)

University of California, San Francisco, San Francisco

RecrutandoEstudo observacional

Idades de 18 a 90 · Todos os sexos · Atualizado em 27 de nov. de 2023 · NCT06146725

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.